CASE REPORT
Langerhans cell sarcoma: a case report and review of the literature
More details
Hide details
Submission date: 2015-10-26
Final revision date: 2016-04-23
Acceptance date: 2016-04-24
Publication date: 2016-08-02
Pol J Pathol 2016;67(2):172-178
KEYWORDS
TOPICS
ABSTRACT
We present the case of a 62-year-old male patient with a three-month history of pain in the left shoulder. Magnetic resonance imaging of the left scapula showed an osteo-destructive lesion. H&E stained sections revealed a Langerhans cell sarcoma, and immunohistochemistry was performed additionally; CD68, CD163, CD14, fascin, HLA-DR, lysozyme, S100 CD1a and langerin showed a positive reaction, while CD20, CD30, CD34, CD31, pan-cytokeratin, AE/1AE3, SMA, desmin, EMA, ERG, INI-1, CD21, CD4, PLAP, MPO and CD117c were negative. We suggested palliative treatment with chemotherapy and radiation. The patient refused any treatment and died 2 weeks later.
REFERENCES (42)
1.
Jaffe R, Weiss LM, Facchetti F. Tumours derived from Langerhans cells. In: Swerdlow SH, Campo E, Harris NL, et al. (eds.). WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon 2008; 358-360.
2.
Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 2002; 41: 1-29.
3.
Kawase T, Hamazaki M, Ogura M, et al. CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of.
4.
4 cases. Int J Hematol 2005; 81: 323-329.
5.
Itoh H, Miyaguni H, Kataoka H, et al. Primary cutaneous Langerhans cell histiocytosis showing malignant phenotype in an elderly woman: report of a fatal case. J Cutan Pathol 2001; 28: 371-378.
6.
Tani M, Ishii N, Kumagai M, Ban M, et al. Malignant Langerhans cell tumour. Br J Dermatol 1992; 126: 398-403.
7.
Misery L, Godard W, Hamzeh H, et al. Malignant Langerhans cell tumor: a case with a favorable outcome associated with the absence of blood dendritic cell proliferation. J Am Acad Dermatol 2003; 49: 527-529.
8.
Ferringer T, Banks PM, Metcalf JS. Langerhans cell sarcoma. Am J Dermatopathol 2006; 28: 36-39.
9.
Jülg BD, Weidner S, Mayr D. Pulmonary manifestation of a Langerhans cell sarcoma: case report and review of the literature. Virchows Arch 2006; 448: 369-374.
10.
Lee JS, Ko GH, Kim HC, et al. Langerhans cell sarcoma arising from Langerhans cell histiocytosis: a case report. J Korean Med Sci 2006; 21: 577-580.
11.
Bohn OL, Ruiz-Argüelles G, Navarro L, et al. Cutaneous Langerhans cell sarcoma: a case report and review of the literature. Int J Hematol 2007; 85: 116-120.
12.
López-Ferrer P, Jiménez-Heffernan JA, Alves-Ferreira J, et al. Fine needle aspiration cytology of Langerhans cell sarcoma. Cytopathology 2008; 19: 59-61.
13.
Sumida K, Yoshidomi Y, Koga H, et al. Leukemic transformation of Langerhans cell sarcoma. Int J Hematol 2008; 87: 527-531.
14.
Deng A, Lee W, Pfau R, et al. Primary cutaneous Langerhans cell sarcoma without Birbeck granules: indeterminate cell sarcoma? J Cutan Pathol 2008; 35: 849-854.
15.
Diaz-Sarrio C, Salvatella-Danés N, Castro-Forns M, et al. Langerhans cell sarcoma in a patient who underwent transplantation. J Eur Acad Dermatol Venereol 2007; 21: 973-976.
16.
Zhao G, Luo M, Wu ZY, et al. Langerhans cell sarcoma involving gallbladder and peritoneal lymph nodes: a case report. Int J Surg Pathol 2009; 17: 347-353.
17.
Uchida K, Kobayashi S, Inukai T, et al. Langerhans cell sarcoma emanating from the upper arm skin: successful treatment by MAID regimen. J Orthop Sci 2008; 13: 89-93.
18.
Ben-Ezra J, Bailey A, Azumi N, et al. Malignant histiocytosis X: a distinct clinicopathologic entity. Cancer 1991; 68: 1050-1060.
19.
Yoshimi A, Kumano K, Motokura T, et al. ESHAP therapy effective in a patient with Langerhans cell sarcoma. Int J Hematol 2008; 87: 532-537.
20.
Li Y, Li B, Tian XY Unusual cutaneous Langerhans cell sarcoma without extracutaneous involvement. Diagn Pathol 2013; 8: 20.
21.
Lakshmaiah KC, Smitha CS, Lokanatha D, et al. Langerhans cell sarcoma – review of literature and a rare case report. J Mol Biomark Diagn 2014; 5: 4.
22.
Chung WD, Im SA, Chung NG, et al. Langerhans cell sarcoma in two young children: imaging findings on initial presentation and recurrence. Korean J Radiol 2013; 14: 520-524.
23.
Kang DW, Son HJ, Baek TH, et al. Langerhans cell sarcoma arising in a lymph node – a case report and review of the literature. Korean J Pathol 2011; 45: 101-105.
24.
Wang YN, Zhou XG, Wang Z. Langerhans cell sarcoma in the cervical lymph node: a case report and literature review. Acta Haematol 2013; 129: 114-120.
25.
Chen W, Jaffe R, Zhang L, et al. Langerhans cell sarcoma arising from chronic lymphocytic lymphoma/small lymphocytic leukemia: lineage analysis and BRAF V600E mutation study. N Am J Med Sci 2013; 5: 386-391.
26.
Wang C, Chen Y, Gao C, et al. Multifocal Langerhans cell sarcoma involving epidermis: a case report and review. Diagn Pathol 2012; 7: 99.
27.
Langfort R, Radzikowska E, Czarnowska E, et al. Langerhans cell sarcoma with pulmonary manifestation, mediastinum involvement and bronchoesophageal fistula. A rare location and difficulties in histopathological diagnosis. Pneumonol Alergol Pol 2009; 77: 327-334.
28.
Yok-Lam Kwong. Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimen. Ann Hematol 2015; 94: 697-699.
29.
Nakayama M, Takahashi K, Hori M, et al. Langerhans cell sarcoma of the cervical lymph node: a case report and literature review. Auris Nasus Larynx 2010; 37: 750-753.
30.
Furmanczyk PS, Lisle AE, Caldwell RB, et al. Langerhans cell sarcoma in a patient with hairy cell leukemia: common clonal origin indicated by identical immunoglobulin gene rearrangements. J Cutan Pathol 2012; 39: 644-650.
31.
Shimizu I, Takeda W, Kirihara T, et al. Long-term remission of Langerhans cell sarcoma by AIM regimen combined with involved-field irradiation. Rinsho Ketsueki 2012; 53: 1911-1915.
32.
Keklik M, Sivgin S, Kontas O, et al. Langerhans cell sarcoma of the nasopharynx: a rare case. Scott Med J 2013; 58: 17-20.
33.
Muslimani A, Chisti MM, Blenc AM, et al. Langerhans/dendritic cell sarcoma arising from hairy cell leukemia: a rare phenomenon. Ann Hematol 2012; 91: 1485-1487.
34.
Valentín-Nogueras SM, Seijo-Montes R, Montalván-Miró E, et al. Langerhans cell sarcoma: a case report. J Cutan Pathol 2013; 40: 670-675.
35.
Xu Z, Padmore R, Faught C. Langerhans cell sarcoma with an aberrant cytoplasmic CD3 expression. Diagn Pathol 2012; 7: 128.
36.
Lucas A, Barca EV, Servitje O, et al. Langerhans cell sarcoma: Response to radiotherapy. Rep Pract Oncol Radiother 2010; 15: 107-109.
37.
Wood C, Wood GS, Deneau DG, et al. Malignant histiocytosis X. Report of a rapidly fatal case in an elderly man. Cancer 1984; 54: 347-352.
38.
Hornick JL, Jaffe ES, Fletcher CD, et al. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 2004; 28: 1133-1144.
39.
Orazi A, Foucar K, Knowles D, Weiss LM (eds.). Knowles’s neoplastic hematopathology. 3rd ed. Lippincott Williams and Wilkins, Philadelphia 2013.
40.
Pinkus GS, Lones MA, Matsumura F, et al. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker. Am J Clin Pathol 2002; 118: 335-343.
41.
Jaffe R, DeVaughn D, Langhoff E. Fascin and the differential diagnosis of childhood histiocytic lesions. Pediatr Dev Pathol 1998; 1: 216-221.
42.
Newton WA Jr, Hamoudi AB. Histiocytosis: a histologic classification with clinical correlation. Perspect Pediatr Pathol 1973; 1: 251-283.